Back to News
Jan 6, 2026 8:10 AM

Enable Injections Announces $30 Million Investment from Sanofi to Accelerate Manufacturing Capabilities

CINCINNATI, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Enable Injections, Inc. ("Enable") a healthcare innovation company developing and manufacturing the enFuse® On-Body Delivery System (OBDS), announced today that Sanofi is making a $30 million investment to accelerate Enable's manufacturing build-out, strengthen its supply chain capabilities, and drive commercial growth.

"This investment from one of our key partners shows support of the enFuse platform and our shared commitment to making large-volume subcutaneous injectable therapies more convenient for patients, including oncology," said Michael D. Hooven, Chairman and CEO of Enable Injections. "Expanding our manufacturing capabilities is key to meeting the needs of our partners while bringing innovative treatment options to patients, worldwide."

This funding will further strengthen Enable's ability to meet growing demand for the enFuse system, which is designed to subcutaneously administer large-volume medicines beginning with the click of a button, ...